Don't Just Read the News, Understand It.
Published loading...Updated

Common Psychiatric Medications May Increase Risk of ALS

  • A nested case-control study published online on June 4 compared 1,057 ALS patients diagnosed between 2015 and 2023 in Sweden with over 5,000 matched controls without motor neuron disease.
  • Researchers investigated whether prescribed anxiolytics, hypnotics, sedatives, or antidepressants were linked to increased ALS risk, accounting for genetic and environmental factors but noting causation remains unclear.
  • The study found a 25% relative increase in ALS risk overall, with odds ratios of 6.1 within one year for hypnotics and sedatives, 1.6 for anxiolytics 1-5 years prior, and 1.2 for antidepressants over five years before diagnosis.
  • Ammar Al-Chalabi highlighted that the impact on disease risk is minimal except during the year just before diagnosis, while neuroscientist Susannah Tye urged careful consideration before linking psychiatric medications directly to increased risk.
  • Amylyx Pharmaceuticals received FDA fast track designation for AMX0114, an antisense oligonucleotide targeting calpain-2 to prevent axonal degeneration in ALS, with a Phase 1 trial ongoing and early data expected later this year.
Insights by Ground AI
Does this summary seem wrong?

13 Articles

All
Left
Center
1
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Patient Worthy broke the news in on Monday, June 9, 2025.
Sources are mostly out of (0)

Similar News Topics